/Investor DB

TEDCO — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Bullfrogaibullfrogai.cominNASDAQ: BFRGApr 2022

BullFrog AI develops AI/ML software for drug discovery that harmonizes fragmented biomedical data and analyzes complex multimodal datasets to identify patient subgroups, drug targets, and biomarkers.

AI & Machine LearningBiotechHealthtechGaithersburg, US

Vin Singh(CEO)inVininder Singh(Chief Executive Officer)Dane Saglia(Chief Financial Officer)

Co-investorsMaryland TEDCO

Quidientquidient.comin𝕏Sep 2022

Quidient develops Spatial AI technology centered on Generalized Scene Reconstruction (GSR), which lets users capture real objects and scenes with a mobile device to build high-accuracy virtual 3D models.

AI & Machine LearningDeep TechEnterprise SoftwareEaston, US

Scott Ackerson(CEO & President)inJohn Leffingwell(CTO & Tech Fellows)inChris Dorsey(CIPO & General Counsel)inNeil Feuling(Chief Product Officer)inBrandon Turley(Director of Operations & CFO)inDavid Scott Ackerson(Executive Officer, Director)

Co-investorsMaryland TEDCO

Vita Therapeuticsvitatx.cominOct 2022

HealthtechBaltimore, US

Douglas Falk(Executive Officer, Director)inVlad Coric(Director)Pat LaVecchia(Director)

Co-investorsEarly Light VenturesMaryland TEDCORiptide Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.